Popular
Tianjin Minxiang Biomedicine Inc is a prominent supplier to the pharmaceutical industry, specialising in providing essential services including Regulatory Services and Active Pharmaceutical Ingredients (APIs).
Description
Tianjin Minxiang Biomedicine Inc is a prominent supplier to the pharmaceutical industry, specialising in providing essential services including Regulatory Services and Active Pharmaceutical Ingredients (APIs). The company is dedicated to supporting pharmaceutical manufacturers with high-quality products and expertise, ensuring compliance with industry standards.
Services include:
- Regulatory Services
- Active Pharmaceutical Ingredients (APIs)
Tianjin Minxiang Biomedicine Inc continues to uphold its reputation as a reliable partner in the pharmaceutical sector, offering comprehensive solutions tailored to client needs. For more information, please visit mxpharm.com.
Certification
China NMPA, ISO 9001, ISO 13485, ISO 14001
Capabilities
Contact Information
Website
Phone
Address
No. 24, FaGang Road, ShuangGang Industrial Zone
Facility Locations
China
[company_related_news_count]
Oragenics Partners with Sterling Pharma Solutions for ONP-002 GMP Manufacturing
17 July 2025
No Comments
Oragenics, Inc., a biotechnology company focused on intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement with Sterling Pharma Solutions, a CDMO with multiple
AGC Biologics to Deliver Cell Line and cGMP Services for Okayama University
17 July 2025
No Comments
AGC Biologics has announced a new agreement with Okayama University, a national academic institution in Japan, to support the development of a novel therapeutic. The
JCR Pharmaceuticals Awarded Japan’s Regenerative CDMO Subsidy for Facility Expansion
17 July 2025
No Comments
JCR Pharmaceuticals Co., Ltd. has been selected for the Japanese Ministry of Economy, Trade and Industry’s (METI) Regenerative CDMO Subsidy programme, the company announced on
Boryung Signs Global Manufacturing Deal with Cheplapharm for Zyprexa
17 July 2025
No Comments
Boryung Corp. has signed a global contract development and manufacturing organisation (CDMO) agreement with Germany-based Cheplapharm for the production and supply of Zyprexa (olanzapine) tablets,
Bora Pharmaceuticals Adds High-Speed Tube Filling Line in Ontario Facility
17 July 2025
No Comments
Bora Pharmaceuticals Co., Ltd. has announced a new investment in its Mississauga, Ontario manufacturing facility with the installation of a high-speed filling line from Norden
Tobin Scientific Opens cGMP Warehouse in Wilmington to Expand Life Sciences Storage
17 July 2025
No Comments
Tobin Scientific, a provider of cGMP-compliant warehousing and transportation solutions, has opened a new 40,000-square-foot facility in Wilmington, Massachusetts. Located 20 miles north of Boston,
Stay ahead of trends and best practices
